Stem cell treatment for poor blood flow in the leg ulcers
Part of Heart & circulation clinical trials.
This trial tests whether a stem cell product (Stempeucel®) can improve healing and safety for people with critical limb ischemia caused by peripheral artery disease. It is for patients who cannot have (or have already tried) procedures to reopen blocked leg arteries and who have a leg ulcer and low blood-flow measurements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your diagnosis is peripheral artery disease caused by atherosclerosis (plaque buildup in arteries).
- You cannot have surgery or a catheter procedure to reopen the blocked artery, or those options have not worked.
- You have at least one leg ulcer, about 0.5 to 10 square centimeters in size.
- Your blood-flow test is low (ABPI 0.6 or less, or if ABPI is not usable, TBI 0.5 or less).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a stem cell product (Stempeucel®) is safe and effective for people with Buerger’s disease causing critical limb ischemia and foot ulcers. It may help improve healing and blood flow when other options may be limited.
This trial tests a cell-based treatment for leg ulcers that haven't healed with standard care in people with severe peripheral artery disease. The goal is to see if this therapy can help wounds heal and improve blood flow.
This study tests whether stem cells taken from donated fat tissue are safe to inject into people with severe leg circulation problems (critical limb ischemia). It aims to see if the treatment is well tolerated and may help improve blood flow and reduce pain.
This study tests a new way to restore blood flow to the leg in people who have wounds or dead tissue on their foot and have run out of other treatment options. It's for those who have already tried angioplasty twice without success or have severely hardened small arteries.
This trial tests a new minimally invasive procedure (placing a small stent) to improve blood flow to a severely threatened foot or lower leg. It may help people whose ulcers or gangrene are not treatable with standard bypass or other surgeries.
This study follows adults with very poor blood flow to the foot or leg (with wounds or severe pain) who are having a revascularization procedure to improve circulation. It may help doctors understand outcomes after treatment and improve care for people with critical limb ischemia.
Hear when a new Critical Limb Ischemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.